InvestorsHub Logo
Followers 19
Posts 334
Boards Moderated 0
Alias Born 07/25/2016

Re: None

Wednesday, 06/21/2017 1:10:56 PM

Wednesday, June 21, 2017 1:10:56 PM

Post# of 48316
This is really interesting, I had missed it ...

The consistent results obtained with these technologies in heterogeneous tissues support reliable intratumoral delivery of a wide variety of DNA-encodable therapeutics across multiple syngeneic, xenograft, and PDX models. Using these technologies, OncoSec has expressed more than fifty proteins in vivo, including multimers and structurally-complex fusion proteins, and no protein tested to date has failed to successfully express/quote]

http://www.prnewswire.com/news-releases/oncosec-announces-technology-access-program-agreement-with-jounce-therapeutics-inc-300472140.html

Can't wait to see the data.